Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10120733 | 1.00 | EIF4E (0.51) | EIF4EAPP | |
| SCHEMBL15096885 | 0.94 | EIF4E (0.48) | EIF4E | |
| SCHEMBL15096774 | 0.94 | EIF4E (0.48) | EIF4E | |
| SCHEMBL1695363 | 0.94 | EIF4E (0.52) | EIF4EAPP | |
| SCHEMBL10120279 | 0.94 | EIF4E (0.52) | EIF4EAPP | |
| SCHEMBL1695358 | 0.94 | EIF4E (0.52) | EIF4EAPP | |
| SCHEMBL15096882 | 0.88 | EIF4E (0.51) | EIF4EAPP | |
| SCHEMBL10120518 | 0.87 | EIF4E (0.49) | EIF4EAPP | |
| SCHEMBL15096770 | 0.85 | EIF4E (0.52) | EIF4EAPP | |
| SCHEMBL10120221 | 0.85 | EIF4E (0.48) | EIF4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8969573-B2 | Compounds for the inhibition of cellular proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2015-03-03 | — | — | US | disclosed |
| US-20130178505-A1 | Compounds for the Inhibition of Cellular Proliferation | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-07-11 | — | — | US | disclosed |
| WO-2012006068-A2 | COMPOUNDS FOR THE INHIBITION OF CELLULAR PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2012-01-12 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130178505-A1 | Compounds for the Inhibition of Cellular Proliferation | MKI67, EIF2AK2, CDK2 | EIF4E 39/4885APP 3540/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.